Αρχική World News “Chameleon-Like” Breast Cancer Cells Disguised as Neurons Can Lead to Brain Metastasis

“Chameleon-Like” Breast Cancer Cells Disguised as Neurons Can Lead to Brain Metastasis

Breast cancer is essentially incapable of taking a life as long as it stays in a person’s breasts and doesn’t spread to other areas of the body. When it metastasizes to important organs like the liver, lungs, bones, or brain, however, it can have disastrous consequences. Therefore, it’s important that breast cancer research emphasizes understanding the mechanisms behind metastasis and works to stop it.

For years, scientists have wondered how cancer cells manage to cross the blood-brain barrier and settle in the brain. Even after a patient has been treated and declared cancer-free, the disease sometimes returns in the brain, a complex issue research has been unable to fully understand. A new study, however, may shed some light on the subject.

Photo: Adobe Stock/stockdevil

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

The study, conducted by City of Hope researchers and led by neurosurgeon Rahul Jandial, investigated how malignant breast cancer cells in the blood stream could cross over the blood-brain barrier and how they could survive in a foreign environment, where there are many proteins and chemicals that are specific to the brain and do not exist in the rest of the body.

The team believed that perhaps cancer cells exploit their new habitat by assuming similar properties to those of brain cells. As it turns out, they were right.

The researchers found that breast cancer cells are capable of using a “chameleon-like” technique to disguise themselves as neurons or neurotransmitters. This allows them to hide from the immune system and avoid getting killed off during treatment, but it also allows them to cross the blood-brain barrier unseen.

Photo: Adobe Stock/prasitphoto

Once in the brain, these chameleon cells begin to form brain tumors, sometimes years after the individual’s initial diagnosis. Because they’re often hard to detect and hard to treat once detected, these tumors are often deadly.

Jandial and his team took samples from brain tumors that had resulted from breast cancer. They learned that the cells were using a chemical that is abundant in the brain, known as GABA, as an alternative fuel source.

Photo: Adobe Stock/Artem

GABA is a neurotransmitter that the brain uses for communication between neurons. Metastatic breast cancer cells, in contrast with non-metastatic breast cancer cells, expressed a receptor for GABA and also one for a protein that pulls the transmitter into cells.

Having these extra receptors allowed breast cancer cells to disguise themselves as neurons, acting as “cellular chameleons” in order to spread to the brain.

Further research may look at what enables breast cancer cells to disguise themselves in this way, as well as how to stop this chameleon process so that breast cancer cells will have a more difficult time spreading to the brain. But for now, this is an important step forward in understanding the mechanism behind this phenomenon.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...